Tag: authorized generics

3

Jul

Do Patients Actually Choose Authorized Generics? The Truth Behind the Label

Do Patients Actually Choose Authorized Generics? The Truth Behind the Label

Explore whether patients actually choose authorized generics over traditional ones. We analyze switchback rates, pricing dynamics, and the hidden role of insurance in your medication choices.

VIEW MORE
22

Jun

Why Authorized Generics Are Rare: The Strategic Limits of Brand-Name Discounts

Why Authorized Generics Are Rare: The Strategic Limits of Brand-Name Discounts

Explore why authorized generics are rare. Learn how brand manufacturers use them strategically during patent exclusivity periods to control competition, impacting drug pricing and consumer choice.

VIEW MORE
7

Jun

Authorized Generics in Patent Litigation: Impact on Competition

Authorized Generics in Patent Litigation: Impact on Competition

Explore how authorized generics disrupt pharmaceutical competition. Learn about their impact on patent litigation, FTC regulations, and the Hatch-Waxman Act.

VIEW MORE
9

Dec

Multiple Generics: How Competitors Enter After the First Generic Drug Launch

Multiple Generics: How Competitors Enter After the First Generic Drug Launch

After the first generic enters the market, a cascade of competitors follows, triggering steep price drops and supply shortages. Learn how patent rules, authorized generics, and manufacturing bottlenecks shape the chaotic race to sell the same drug.

VIEW MORE